While we demonstrated downregulation of RXRα expression in the colorectal cancer samples in the array, we did not have access to pertinent clinical information to correlate tumor phenotype with impaired RXRα expression and possible associations with CIMP+ status. This evidence concerns the gene RXRA and colorectal cancer.